Published in Nowotwory on September 15, 1988
Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch (2001) 10.93
Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol (1999) 4.48
Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol (2001) 3.04
Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol (2001) 2.74
Gastrointestinal stromal tumours. Ann Chir Gynaecol (1998) 2.22
Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol (2000) 2.00
Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol (2000) 1.63
Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology (1995) 1.62
Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol (2001) 1.41
Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol (1990) 1.40
Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol (2001) 1.33
Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol (1990) 1.26
Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. Mod Pathol (1999) 1.22
Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut (2004) 1.22
KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol (2000) 1.17
Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics (1992) 1.15
Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology (1977) 1.09
Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutation. Cancer Genet Cytogenet (2001) 1.05
Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol (1990) 1.03
Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases. Vet Pathol (2003) 0.98
Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). Cancer Res (1993) 0.93
Carcinosarcoma of the skin. Case report and literature review. Am J Dermatopathol (1996) 0.91
Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch (2000) 0.90
KIT-positive gastrointestinal stromal tumor in a 22-year-old male chimpanzee (Pan troglodites). Vet Pathol (2005) 0.89
Characterization of human bone marrow-derived closed circular DNA clones. Genes Chromosomes Cancer (1993) 0.88
[The behavior of mast cells in precancerous conditions and epithelial neoplasms of the skin]. Hautarzt (1968) 0.87
Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res (1995) 0.86
Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland. Neoplasma (2006) 0.85
True histiocytic lymphoma of small intestine. Analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. Am J Clin Pathol (1993) 0.85
Chromosomal localization of four human zinc finger cDNAs. Hum Genet (1993) 0.85
Estrogen and progesterone receptor status in breast cancer in Kuwait female population. Neoplasma (1993) 0.84
Structure of the human receptor tyrosine phosphatase gamma gene (PTPRG) and relation to the familial RCC t(3;8) chromosome translocation. Genomics (1996) 0.83
The human ryk cDNA sequence predicts a protein containing two putative transmembrane segments and a tyrosine kinase catalytic domain. Oncogene (1993) 0.82
A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue. Neoplasma (2005) 0.81
CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfall. Mod Pathol (1998) 0.81
Diagnosis of major tumor categories in fine-needle aspirates is more accurate when light microscopy is combined with intermediate filament typing. A study of 403 cases. Cancer (1989) 0.81
[Differentiation signs of X-chromosomal recessive and autosome dominant ichthyosis vulgaris]. Dermatol Monatsschr (1970) 0.80
Neuroendocrine (Merkel-cell) carcinoma of the skin. Cytology, intermediate filament typing and ultrastructure of tumor cells in fine needle aspirates. Acta Cytol (1987) 0.80
Molecular pathological analysis of testicular diffuse large cell lymphomas. Hum Pathol (1998) 0.80
Relations between epidermal growth factor receptor and oestrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients in Kuwait. Eur J Cancer (1992) 0.79
Estrogen and progestin receptor levels in uterine leiomyomata: relation to the tumour histology and the phase of menstrual cycle. Eur J Gynaecol Oncol (1990) 0.79
The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives. Eur J Gynaecol Oncol (2004) 0.79
Estrogen receptor in human breast cancer in relation to tumor morphology and endocrine therapy. Tumori (1978) 0.78
[Micromorphological differences between various forms of ichthyoses]. Dermatol Monatsschr (1972) 0.78
Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma--performance in formaldehyde-fixed tissue and application in clinical problem cases. Pathol Res Pract (1997) 0.78
Papillary eccrine adenoma--a case of cutaneous sweat gland tumor with secretory and ductular differentiation. Pol J Pathol (1994) 0.78
Epidermal growth factor receptor and estrogen and progesterone receptors in breast cancers of premenopausal and postmenopausal patients. Tumori (1994) 0.77
Leukocyte-common antigen and vimentin are reliable adjuncts in the diagnosis of non-Hodgkin's lymphoma in fine needle aspirates. Anal Quant Cytol Histol (1989) 0.77
Expression of the latent membrane protein of Epstein-Barr virus in Hodgkin's disease. Age and subtype distribution in Polish patients. Acta Haematol Pol (1996) 0.77
Immunoreactive and estrogen-binding estrogen receptors, and progestin receptor levels in uterine leiomyomata and their parental myometrium. Eur J Gynaecol Oncol (1990) 0.77
Decisive role of intermediate filament typing of tumor cells in the differential diagnosis of difficult fine needle aspirates. Acta Cytol (1987) 0.76
[Evaluation of therapeutic results in various morphologic types of malignant choroid melanoma]. Klin Monbl Augenheilkd (1972) 0.76
Neuroendocrine (Merkel cell) carcinoma of the skin: a clinico-morphological study of 13 cases. Histopathology (1989) 0.76
Cutaneous lymphoma-simulating Merkel cell carcinoma-molecular genetic demonstration of a clonal disease with divergent immunophenotypes. Mod Pathol (1995) 0.75
[Amenorrhea-galactorrhea and hyperprolactinemia as indicators of the presence of pituitary adenoma - prolactinoma]. Pol Tyg Lek (1983) 0.75
[Levels of estrogen and progestagen receptors in uterine myomas in women during the menstrual cycle]. Nowotwory (1988) 0.75
Concentration and separation of FSH and LH from human pituitaries. Arch Immunol Ther Exp (Warsz) (1971) 0.75
[Hyperprolactinemia and galactorrhea in women after head injuries]. Pol Tyg Lek (1981) 0.75
[Comparison of the accuracy of determination of blood serum concentrations of chorionic gonadotropins in pregnancy by the radioligand assay and radioimmunoassay]. Ginekol Pol (1980) 0.75
[Evaluation of tamoxifen in the treatment of female patients with advanced breast cancer]. Nowotwory (1986) 0.75
[Human gonadotropins. II. Synthesis, concentration and isolation of LH activity from FSH activity]. Postepy Hig Med Dosw (1972) 0.75
[Condensation of gonadotropins from the urine of postmenopausal women]. Endokrynol Pol (1969) 0.75
[Serum prolactin level in women with hypothyroidism after menopause]. Pol Tyg Lek (1987) 0.75
[Changes in contents of pituitary gonadotropins in castrated rats following implantation of ovaries into the kidneys]. Endokrynol Pol (1971) 0.75
Effect of median raphe nucleus electrocoagulation and serotonin synthesis blockade on oestrogen receptor content of rat uterus. Acta Physiol Pol (1983) 0.75
[Human gonadotropins. I. Selected problems from the field of biologic methods in detection of gonadotropins]. Postepy Hig Med Dosw (1971) 0.75
[Steroid hormone receptors; their appearance in breast cancer; usefulness of the findings in the selection of patients for endocrine therapy and prognosis of tumor development]. Pol Tyg Lek (1984) 0.75
The effect of actinomycin D on nucleic acid, protein, and lipid synthesis and contents of ascorbic acid and cholesterol influenced by LH in the luteinized rat ovary. Arch Immunol Ther Exp (Warsz) (1973) 0.75
[Nuclear estrogen receptors in women with breast cancer]. Nowotwory (1988) 0.75
[Estrogen activity and prolactin secretion in menopausal women at high risk of developing breast cancer]. Nowotwory (1984) 0.75
[Relationship between the effects of endocrinological treatment of breast cancer and the presence of estrogen receptor in the cancer tissue]. Nowotwory (1980) 0.75
Purification of pituitary gonadotropins from the urine of women after menopause and trials of separating luteinizing from follicle stimulating hormone. Arch Immunol Ther Exp (Warsz) (1969) 0.75
Isolation of lymphocyte growth factor from the seeds of the kidney bean. Arch Immunol Ther Exp (Warsz) (1968) 0.75
[Prolactin levels and indicators of breast cancer risk in women with mastopathy]. Nowotwory (1982) 0.75
[Levels of estrogen and progestagen receptors in the endometrium and myometrium of women during the menstrual cycle]. Nowotwory (1988) 0.75
Studies on the application of the hormone-receptor reaction for determination of HCG or LH in human serum and urine. Endokrynol Pol (1981) 0.75
Quality control program of steroid receptor assays: an international study. Neoplasma (1992) 0.75
[Immunocytochemical evaluation of estrogen receptors in histological specimens of primary breast cancer]. Patol Pol (1990) 0.75
[Amenorrhea-galactorrhea syndrome: clinical characteristics, prolactin secretion and estrogenic activity]. Ginekol Pol (1983) 0.75
[Detection of specific prolactin binding sites in cell membranes of the rat liver]. Endokrynol Pol (1981) 0.75
[Prolactin secretion in patients with diabetes mellitus - TRH or bromocriptine function tests]. Endokrynol Pol (1982) 0.75
The influence of LH on synthesis of RNA, DNA, proteins and lipids and content of ascorbic acid and cholesterol in the luteinized rat ovary. Arch Immunol Ther Exp (Warsz) (1972) 0.75
[Evaluation of the growing activity of human growth hormone]. Endokrynol Pol (1967) 0.75
Comparison of luteinizing hormone and human chorionic gonadotrophin determinations by biological, radioreceptor and radioimmunoassay methods. Endokrynol Pol (1981) 0.75
[Hormones and breast neoplasms]. Nowotwory (1979) 0.75
[Pathogenesis of thyroid regeneration in women following strumectomy]. Pol Tyg Lek (1982) 0.75
[Determining estrogen receptors in neoplastic and normal human tissues: comparison of immunoenzyme and radioligand methods]. Nowotwory (1989) 0.75
[Prolactin in the polycystic ovary syndrome (Stein-Leventhal syndrome)]. Ginekol Pol (1983) 0.75
Neutralization of LH and FSH activity in gonadotropin preparations (HMG) by means of anti-HCG immune serum. Arch Immunol Ther Exp (Warsz) (1971) 0.75
[Morphological structure of uterine myomas and levels of estrogen and progestagen receptors]. Nowotwory (1988) 0.75
[Occurrence of 4S and 8S forms of estrogen and progestin receptors in the cytosol of breast cancer in women]. Nowotwory (1983) 0.75
[Changes in the estrogen receptor content in the growing uterus of an immature rat after gonadotropin (PMSG, HCG) or estrogen injection]. Endokrynol Pol (1982) 0.75
[An attempt to eliminate a high luteinizing hormone content from pituitary gonadotropin preparation of human menopausal urine origin and a further study of chorionic concentration]. Endokrynol Pol (1970) 0.75
[Hormones and breast neoplasms]. Nowotwory (1978) 0.75
[Effect of sex hormones on the content of prolactin receptor in the liver of female rats]. Endokrynol Pol (1980) 0.75
[Diurnal rhythm of prolactin secretion in patients with type I diabetes mellitus]. Pol Tyg Lek (1982) 0.75